← Open Payments lookup

DAVID CHAPPELL: Open Payments

NPI 1598732463 · PETALUMA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,244 in 51 payments from 14 companies in 2025. Trend: 2023 $1,357 · 2024 $1,791 · 2025 $1,244

Food & beverage: $1,244
CompanyPaymentsAmount
Lilly USA, LLC10$242
Novo Nordisk Inc10$225
Boehringer Ingelheim Pharmaceuticals, Inc.6$148
Xeris Pharmaceuticals, Inc.6$138
Bayer Healthcare Pharmaceuticals Inc.5$125
Amgen Inc.4$117
ABBVIE INC.3$82
Ascendis Pharma Endocrinology Inc1$28
Dexcom, Inc.1$27
Novartis Pharmaceuticals Corporation1$27

Products named: JARDIANCE, RECORLEV, Kerendia, MOUNJARO, Ozempic, TEPEZZA, QULIPTA, Wegovy.

Industry payments across CA — which companies pay providers there.